当前位置:首页 - 行情中心 - 天目药业(600671) - 财务分析 - 资产负债表

天目药业

(600671)

  

流通市值:24.23亿  总市值:24.25亿
流通股本:1.22亿   总股本:1.22亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金44,800,796.7131,888,531.711,740,346.3425,367,141.74
  应收票据及应收账款157,954,828.24146,012,703.73152,820,152.54113,431,446.03
  其中:应收票据4,281,441.752,175,528.78--
        应收账款153,673,386.49143,837,174.95152,820,152.54113,431,446.03
  应收款项融资578,172.73675,555.171,441,949.8325,852.94
  预付款项6,075,661.274,919,252.37,300,284.062,978,010.75
  其他应收款合计1,522,231.681,341,801.011,671,418.21,854,557.39
  存货41,599,237.2439,184,579.4541,498,781.0445,798,426.86
  其他流动资产4,060,156.014,454,673.364,066,448.524,656,628.79
  流动资产合计256,591,083.88228,477,096.72220,539,380.5194,412,064.5
非流动资产:
  固定资产151,831,029.26155,207,687.97158,011,835.2160,803,593.93
  在建工程19,372,184.2918,106,578.7113,252,874.179,093,268.1
  使用权资产18,406,133.0820,538,188.416,322,940.9917,711,435.11
  无形资产4,969,535.365,011,065.115,080,159.35,099,221.2
  商誉1,614,611.741,614,611.741,614,611.741,614,611.74
  长期待摊费用2,985,660.083,155,539.118,897,070.7710,014,215.8
  递延所得税资产9,056,020.269,864,459.276,008,434.535,958,537.42
  其他非流动资产55,752.2255,752.22--
  非流动资产合计208,290,926.29213,553,882.53209,187,926.7210,294,883.3
  资产总计464,882,010.17442,030,979.25429,727,307.2404,706,947.8
流动负债:
  短期借款178,924,973.65144,301,959.66156,180,940132,563,243.75
  应付票据及应付账款73,817,903.2980,904,157.3573,544,433.2177,601,637.42
  其中:应付票据6,703,448.184,667,026.42,964,570.488,325,632.84
        应付账款67,114,455.1176,237,130.9570,579,862.7369,276,004.58
  合同负债3,646,102.573,348,822.453,320,372.042,356,005.07
  应付职工薪酬3,352,042.184,249,391.013,457,494.162,915,292.44
  应交税费8,782,993.669,227,354.636,888,422.794,343,460.18
  其他应付款合计23,961,882.3925,511,496.3621,507,387.5719,766,084.8
        应付股利23,403.3623,403.3623,403.3623,403.36
  一年内到期的非流动负债12,555,880.9213,301,684.458,004,538.567,532,027.5
  其他流动负债467,676.661,577,665.62425,644.65299,737.4
  流动负债合计305,509,455.32282,422,531.53273,329,232.98247,377,488.56
非流动负债:
  租赁负债7,509,950.748,650,236.249,386,653.389,590,275.4
  预计负债2,358,248.362,358,248.36476,367.66476,367.66
  递延收益45,166,836.6846,649,683.248,157,342.8249,648,225.66
  递延所得税负债7,255,682.887,958,433.434,080,735.264,427,858.78
  非流动负债合计62,290,718.6665,616,601.2362,101,099.1264,142,727.5
  负债合计367,800,173.98348,039,132.76335,430,332.1311,520,216.06
所有者权益(或股东权益):
  实收资本(或股本)121,778,885121,778,885121,778,885121,778,885
  资本公积162,787,915.98162,787,915.98162,787,915.98162,787,915.98
  盈余公积24,181,414.3724,181,414.3724,181,414.3724,181,414.37
  未分配利润-234,925,608.6-238,741,712.96-242,155,533.95-246,116,521.81
  归属于母公司股东权益合计73,822,606.7570,006,502.3966,592,681.462,631,693.54
  少数股东权益23,259,229.4423,985,344.127,704,293.730,555,038.2
  股东权益合计97,081,836.1993,991,846.4994,296,975.193,186,731.74
  负债和股东权益合计464,882,010.17442,030,979.25429,727,307.2404,706,947.8
公告日期2026-04-302026-04-182025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑